BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 27465917)

  • 21. IL-21 induces the functional maturation of murine NK cells.
    Brady J; Hayakawa Y; Smyth MJ; Nutt SL
    J Immunol; 2004 Feb; 172(4):2048-58. PubMed ID: 14764669
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Suppressor of cytokine signaling 2 regulates IL-15-primed human NK cell function via control of phosphorylated Pyk2.
    Lee SH; Yun S; Piao ZH; Jeong M; Kim DO; Jung H; Lee J; Kim MJ; Kim MS; Chung JW; Kim TD; Yoon SR; Greenberg PD; Choi I
    J Immunol; 2010 Jul; 185(2):917-28. PubMed ID: 20543098
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Phenotype and Function of Activated Natural Killer Cells From Patients With Prostate Cancer: Patient-Dependent Responses to Priming and IL-2 Activation.
    Hood SP; Foulds GA; Imrie H; Reeder S; McArdle SEB; Khan M; Pockley AG
    Front Immunol; 2018; 9():3169. PubMed ID: 30761160
    [No Abstract]   [Full Text] [Related]  

  • 24. Engineering of Anti-CD133 Trispecific Molecule Capable of Inducing NK Expansion and Driving Antibody-Dependent Cell-Mediated Cytotoxicity.
    Schmohl JU; Felices M; Oh F; Lenvik AJ; Lebeau AM; Panyam J; Miller JS; Vallera DA
    Cancer Res Treat; 2017 Oct; 49(4):1140-1152. PubMed ID: 28231426
    [TBL] [Abstract][Full Text] [Related]  

  • 25. IL-18/IL-15/IL-12 synergy induces elevated and prolonged IFN-γ production by ex vivo expanded NK cells which is not due to enhanced STAT4 activation.
    Lusty E; Poznanski SM; Kwofie K; Mandur TS; Lee DA; Richards CD; Ashkar AA
    Mol Immunol; 2017 Aug; 88():138-147. PubMed ID: 28644973
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The metabolic checkpoint kinase mTOR is essential for IL-15 signaling during the development and activation of NK cells.
    Marçais A; Cherfils-Vicini J; Viant C; Degouve S; Viel S; Fenis A; Rabilloud J; Mayol K; Tavares A; Bienvenu J; Gangloff YG; Gilson E; Vivier E; Walzer T
    Nat Immunol; 2014 Aug; 15(8):749-757. PubMed ID: 24973821
    [TBL] [Abstract][Full Text] [Related]  

  • 27. IL-2 increases human telomerase reverse transcriptase activity transcriptionally and posttranslationally through phosphatidylinositol 3'-kinase/Akt, heat shock protein 90, and mammalian target of rapamycin in transformed NK cells.
    Kawauchi K; Ihjima K; Yamada O
    J Immunol; 2005 May; 174(9):5261-9. PubMed ID: 15843522
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Culturing the Human Natural Killer Cell Line NK-92 in Interleukin-2 and Interleukin-15 - Implications for Clinical Trials.
    Törnroos H; Hägerstrand H; Lindqvist C
    Anticancer Res; 2019 Jan; 39(1):107-112. PubMed ID: 30591446
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tethering IL2 to Its Receptor IL2Rβ Enhances Antitumor Activity and Expansion of Natural Killer NK92 Cells.
    Jounaidi Y; Cotten JF; Miller KW; Forman SA
    Cancer Res; 2017 Nov; 77(21):5938-5951. PubMed ID: 28916655
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rapid generation of potent and tumor-specific cytotoxic T lymphocytes by interleukin 18 using dendritic cells and natural killer cells.
    Tanaka F; Hashimoto W; Okamura H; Robbins PD; Lotze MT; Tahara H
    Cancer Res; 2000 Sep; 60(17):4838-44. PubMed ID: 10987295
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The cytotoxic potential of interleukin-15-stimulated cytokine-induced killer cells against leukemia cells.
    Rettinger E; Kuçi S; Naumann I; Becker P; Kreyenberg H; Anzaghe M; Willasch A; Koehl U; Bug G; Ruthardt M; Klingebiel T; Fulda S; Bader P
    Cytotherapy; 2012 Jan; 14(1):91-103. PubMed ID: 21973023
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Memory type 2 helper T cells induce long-lasting antitumor immunity by activating natural killer cells.
    Kitajima M; Ito T; Tumes DJ; Endo Y; Onodera A; Hashimoto K; Motohashi S; Yamashita M; Nishimura T; Ziegler SF; Nakayama T
    Cancer Res; 2011 Jul; 71(14):4790-8. PubMed ID: 21646476
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genetically re-engineered K562 cells significantly expand and functionally activate cord blood natural killer cells: Potential for adoptive cellular immunotherapy.
    Ayello J; Hochberg J; Flower A; Chu Y; Baxi LV; Quish W; van de Ven C; Cairo MS
    Exp Hematol; 2017 Feb; 46():38-47. PubMed ID: 27765614
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differential regulation of interleukin-12- and interleukin-15-induced natural killer cell activation by interleukin-4.
    Salvucci O; Mami-Chouaib F; Moreau JL; Thèze J; Chehimi J; Chouaib S
    Eur J Immunol; 1996 Nov; 26(11):2736-41. PubMed ID: 8921963
    [TBL] [Abstract][Full Text] [Related]  

  • 35. TRAIL-mediated killing of acute lymphoblastic leukemia by plasmacytoid dendritic cell-activated natural killer cells.
    Lelaidier M; Dìaz-Rodriguez Y; Cordeau M; Cordeiro P; Haddad E; Herblot S; Duval M
    Oncotarget; 2015 Oct; 6(30):29440-55. PubMed ID: 26320191
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differential transcriptional regulation of CD161 and a novel gene, 197/15a, by IL-2, IL-15, and IL-12 in NK and T cells.
    Azzoni L; Zatsepina O; Abebe B; Bennett IM; Kanakaraj P; Perussia B
    J Immunol; 1998 Oct; 161(7):3493-500. PubMed ID: 9759869
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Endogenous IL-2 production by natural killer cells maintains cytotoxic and proliferative capacity following retroviral-mediated gene transfer.
    Miller JS; Tessmer-Tuck J; Blake N; Lund J; Scott A; Blazar BR; Orchard PJ
    Exp Hematol; 1997 Oct; 25(11):1140-8. PubMed ID: 9328450
    [TBL] [Abstract][Full Text] [Related]  

  • 38. hIL-15-gene modified human natural killer cells (NKL-IL15) exhibit anti-human leukemia functions.
    Jiang W; Zhang C; Tian Z; Zhang J
    J Cancer Res Clin Oncol; 2018 Jul; 144(7):1279-1288. PubMed ID: 29737430
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Anti-ovarian tumor response of donor peripheral blood mononuclear cells is due to infiltrating cytotoxic NK cells.
    Pandey V; Oyer JL; Igarashi RY; Gitto SB; Copik AJ; Altomare DA
    Oncotarget; 2016 Feb; 7(6):7318-28. PubMed ID: 26802025
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Upregulation of Natural Killer Cells Proliferation by Cytokine Stimulation.
    Pencheva-Demireva M; El-Darawish Y; Kavaldzhieva K; Mladenov N; Lazarov V; Dimitrova-Dikanarova D; Markova T; Nikolov R; Okamura H
    Monoclon Antib Immunodiagn Immunother; 2019 Apr; 38(2):85-88. PubMed ID: 31009333
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.